Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v3.23.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Jun. 30, 2022
Dec. 31, 2021
Jun. 30, 2023
Jun. 30, 2022
Sep. 30, 2022
Cash flows from operating activities:              
Net income (loss) $ 8,671 $ 3,647 $ 2,875 $ (19,810) $ 21,443 $ (18,871)  
Adjustments to reconcile net income (loss) to net cash flows from operating activities:              
Depreciation and amortization 23,936   22,938   71,813 80,163  
Stock-based compensation expense         13,635 14,128  
Deferred tax provision (benefit)         680 (2,712)  
Loss (gain) on sale of assets, net         594 (514)  
Asset write-downs 0   (469)   0 10,017 $ 10,017
Defined benefit plan settlement losses         1,271 30,856  
Defined benefit plan settlement payments         (24,242) (35,706)  
Proceeds from the settlement of cash flow hedges         10,474 0  
Changes in working capital items         (16,131) (8,393)  
Decrease in other assets         4,313 14,923  
Decrease in other liabilities         (4,748) (9,131)  
Other operating activities, net         (2,196) 9,607  
Net cash provided by operating activities         76,906 84,367  
Cash flows from investing activities:              
Capital expenditures         (37,107) (40,597)  
Acquisitions, net of cash acquired         (15,341) 0  
Proceeds from sale of investments         0 3,127  
Purchases of investments         (1,536) (2,198)  
Other investing activities, net         267 739  
Net cash used in investing activities         (53,717) (38,929)  
Cash flows from financing activities:              
Proceeds from long-term debt         612,052 565,408  
Payments on long-term debt         (643,494) (551,645)  
Purchases of treasury stock         (2,818) (33,986)  
Dividends         (21,184) (20,812)  
Acquisition holdback and contingent consideration payments         0 (613)  
Other financing activities         (913) (2,128)  
Net cash used in financing activities         (56,357) (43,776)  
Effect of exchange rate changes on cash         1,049 (3,862)  
Net change in cash, cash equivalents and restricted cash         (32,119) (2,200)  
Cash, cash equivalents and restricted cash at beginning of year   $ 71,414   $ 68,343 71,414 68,343 68,343
Cash, cash equivalents and restricted cash at end of period $ 39,295   $ 66,143   $ 39,295 $ 66,143 $ 71,414